Gen-Sheng Feng

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Advanced Cancer

Protein Protein

Cancer Stem Cells

Top Venues

Hepatology communications

FASEB bioAdvances

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jin Lee, Kaisa L Hanley, Gen-Sheng Feng
The most impactful findings on liver cancer in 2023. Hepatology communications 8 (4) (2024)
Jin Lee, Kaisa L Hanley, Gen-Sheng Feng
The most impactful findings on liver cancer in 2023. Hepatology communications 8 (4) (2024)
Jin Lee, Kaisa L Hanley, Gen-Sheng Feng
The most impactful findings on liver cancer in 2023. Hepatology communications 8 (4) (2024)
Jin Lee, Kaisa L Hanley, Gen-Sheng Feng
The most impactful findings on liver cancer in 2023. Hepatology communications 8 (4) (2024)
Kota Kaneko, Yan Liang, Qing Liu, Shuo Zhang, Alexander Scheiter, Dan Song, Gen-Sheng Feng
Identification of CD133 + intercellsomes in intercellular communication to offset intracellular signal deficit. eLife 12 (2023)
Jacey J Liu, Bing Xin, Li Du, Lydia Chen, Yanyan Long, Gen-Sheng Feng
Pharmaceutical SH2 domain-containing protein tyrosine phosphatase 2 inhibition suppresses primary and metastasized liver tumors by provoking hepatic innate immunity. Hepatology (Baltimore, Md.) (2022)
Shoib Sarwar Siddiqui, Michael Vaill, Raymond Do, Naazneen Khan, Andrea L Verhagen, Wu Zhang, Heinz-Josef Lenz, Teresa L Johnson-Pais, Robin J Leach, Gary E Fraser, Charles Wang, Gen-Sheng Feng, Nissi Varki, Ajit Varki
Human-specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression. FASEB bioAdvances 3 (2) (2020)